Genotype MTBDRplus for Direct Detection of Mycobacterium tuberculosis and Drug Resistance in Strains from Gold Miners in South Africa

被引:38
|
作者
Dorman, Susan E. [1 ]
Chihota, Violet N. [2 ]
Lewis, James J. [2 ,3 ]
van der Meulen, Minty [2 ]
Mathema, Barun [4 ]
Beylis, Natalie [5 ]
Fielding, Katherine L. [3 ]
Grant, Alison D. [3 ]
Churchyard, Gavin J. [2 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] London Sch Hyg & Trop Med, London WC1, England
[4] Publ Hlth Res Inst, TB Ctr, Newark, NJ USA
[5] Natl Hlth Lab Serv, Braamfontein, South Africa
基金
美国国家卫生研究院;
关键词
BACTEC MGIT 960; CLINICAL SPECIMENS; LOWENSTEIN-JENSEN; CULTURE; ASSAY; RIFAMPIN; DIAGNOSIS; RECOVERY; SYSTEM; IMPACT;
D O I
10.1128/JCM.05723-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
GenoType MTBDRplus is a molecular assay for detection of Mycobacterium tuberculosis and drug resistance. Assay performance as applied directly to consecutive unselected sputum samples has not been established. The objective of this study was to determine the accuracy of the MTBDRplus test for direct detection of M. tuberculosis (in sputum) and for drug resistance in consecutively submitted sputum samples. In this cross-sectional study in South Africa, one sputum specimen from each person suspected of having pulmonary tuberculosis was tested by smear microscopy, direct MTBDRplus, and Mycobacterial Growth Indicator Tube (MGIT) culture with MGIT drug susceptibility testing. MGIT results were the reference standard. We tested 2,510 sputum samples, and 529 (21.1%) were positive for M. tuberculosis by MGIT. Direct MTBDRplus identified M. tuberculosis in 256 of 529 specimens (sensitivity, 48.4%; 95% confidence interval [CI], 44.1, 52.7). The sensitivity of MTBDRplus for M. tuberculosis detection by sputum smear status was as follows: smear negative, 13.7% (95% CI, 9.8, 18.4); smear scanty, 46.2% (95% CI, 19.2, 74.9); smear 1+, 69.1% (95% CI, 55.2, 80.9); smear 2+, 86.3% (95% CI, 73.7, 94.3); smear 3+, 89.8% (95% CI, 83.7, 94.2). Direct MTBDRplus testing was negative for 1,594/1,612 sputum samples that were culture negative for M. tuberculosis (specificity, 98.9%; 95% CI, 98.2, 99.3). For specimens positive for M. tuberculosis by MTBDRplus, this assay's sensitivity and specificity for rifampin resistance were 85.7% (95% CI, 57.2, 98.2) and 96.6% (95% CI, 93.2, 98.6) and for isoniazid resistance they were 62.1% (95% CI, 42.3, 79.3) and 97.9% (95% CI, 94.8, 99.4). For sputum testing, the sensitivity of MTBDRplus is directly related to the specimen's bacillary burden. Our results support recommendations that the MTBDRplus test not be used for direct testing of smear-negative or paucibacillary sputum samples.
引用
收藏
页码:1189 / 1194
页数:6
相关论文
共 50 条
  • [1] The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden
    Chryssanthou, Erja
    Angeby, Kristiana
    [J]. APMIS, 2012, 120 (05) : 405 - 409
  • [2] Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype® MTBDRplus
    Goncalves dos Santos, Paula Fernanda
    Dalla Costa, Elis Regina
    Ramalho, Daniela M.
    Rossetti, Maria Lucia
    Barcellos, Regina Bones
    Nunes, Luciana de Souza
    Esteves, Leonardo Souza
    Rodenbusch, Rodrigo
    Anthony, Richard M.
    Bergval, Indra
    Sengstake, Sarah
    Viveiros, Miguel
    Kritski, Afrnio
    Oliveira, Martha M.
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2017, 112 (06): : 396 - 403
  • [3] Evaluation of new GenoType® MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis
    Causse, M.
    Ruiz, P.
    Gutierrez, J. B.
    Zerolo, J.
    Casal, M.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (12) : 1456 - 1460
  • [4] GenoType MTBDRplus Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Samples
    Lacoma, A.
    Garcia-Sierra, N.
    Prat, C.
    Ruiz-Manzano, J.
    Haba, L.
    Roses, S.
    Maldonado, J.
    Dominguez, J.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (11) : 3660 - 3667
  • [5] Evaluation of FluoroType MTB for direct detection of Mycobacterium tuberculosis complex and GenoType MTBDRplus for determining rifampicin and isoniazid resistance
    Genc, Gonca Erkose
    Satana, Dilek
    Yildirim, Esra
    Erturan, Zayre
    Yegenoglu, Yildiz
    Uzun, Meltem
    [J]. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2018, 32 (04) : 999 - 1004
  • [6] Evaluation of genotype MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex strains and clinical samples
    Spatharaki, Paraskevi
    Kontos, Fanourios
    Mavromanolakis, Dimitrios
    Gitti, Zoe
    Spandidos, Demetrios A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S24 - S24
  • [7] Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay
    Singhal, R.
    Myneedu, V. P.
    Arora, J.
    Singh, N.
    Bhalla, M.
    Verma, A.
    Sarin, R.
    [J]. INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 : S46 - S52
  • [8] Early detection of multi-drug resistant tuberculosis in India using GenoType MTBDRplus assay & profile of resistance mutations in Mycobacterium tuberculosis
    Singh, Sarman
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2014, 140 : 477 - 479
  • [9] Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China
    Jian, Jiyong
    Yang, Xinyu
    Yang, Jun
    Chen, Liang
    [J]. INFECTION AND DRUG RESISTANCE, 2018, 11 : 1627 - 1634
  • [10] GenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis
    Bai, Yuanyuan
    Wang, Yueling
    Shao, Chunhong
    Hao, Yingying
    Jin, Yan
    [J]. PLOS ONE, 2016, 11 (03):